MIRA Pharmaceuticals (NASDAQ: MIRA) Stock Rallies; Investors High on News of preclinical study results for oral ketamine analog, Ketamir-2

MIRA Pharmaceuticals (NASDAQ: MIRA) Stock Rallies; Investors High on News of preclinical study results for oral ketamine analog, Ketamir-2: MIRA Pharmaceuticals (NASDAQ: MIRA) Stock Rallies; Investors High on News of preclinical study results for oral ketamine analog, Ketamir-2